Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review

Federica Sora'; Mario Annunziata; Luca Laurenti; Sabrina Giammarco; Patrizia Chiusolo; Idanna Innocenti; Francesco Autore; Elisabetta Metafuni; Eugenio Galli; Andrea Bacigalupo; Felicetto Ferrara; Simona Sica

doi:10.1002/pbc.29044

Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review

Federica Sora'
, Mario Annunziata
, Luca Laurenti
, Sabrina Giammarco
, Patrizia Chiusolo
, Idanna Innocenti
, Francesco Autore
, Elisabetta Metafuni
, Eugenio Galli
, Andrea Bacigalupo
, Felicetto Ferrara
, Simona Sica^*

^*Corresponding author

Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli

Research output: Contribution to journal › Article

Abstract

NOT AVAILABLE

Original language	English
Pages (from-to)	29044-29044
Number of pages	1
Journal	PEDIATRIC BLOOD & CANCER
Volume	68
Issue number	7
DOIs	https://doi.org/10.1002/pbc.29044
Publication status	Published - 2021

All Science Journal Classification (ASJC) codes

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Keywords

BLINATUMOMAB DOWN

Access to Document

10.1002/pbc.29044

Cite this

Sora', F., Annunziata, M., Laurenti, L., Giammarco, S., Chiusolo, P., Innocenti, I., Autore, F., Metafuni, E., Galli, E., Bacigalupo, A., Ferrara, F., & Sica, S. (2021). Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review. PEDIATRIC BLOOD & CANCER, 68(7), 29044-29044. https://doi.org/10.1002/pbc.29044

@article{092480b68e584a04ab841276696c0299,

title = "Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review",

abstract = "NOT AVAILABLE",

keywords = "BLINATUMOMAB DOWN, BLINATUMOMAB DOWN",

author = "Federica Sora' and Mario Annunziata and Luca Laurenti and Sabrina Giammarco and Patrizia Chiusolo and Idanna Innocenti and Francesco Autore and Elisabetta Metafuni and Eugenio Galli and Andrea Bacigalupo and Felicetto Ferrara and Simona Sica",

year = "2021",

doi = "10.1002/pbc.29044",

language = "English",

volume = "68",

pages = "29044--29044",

journal = "PEDIATRIC BLOOD \& CANCER",

issn = "1545-5009",

number = "7",

}

Sora', F, Annunziata, M, Laurenti, L, Giammarco, S, Chiusolo, P, Innocenti, I, Autore, F, Metafuni, E, Galli, E, Bacigalupo, A, Ferrara, F & Sica, S 2021, 'Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review', PEDIATRIC BLOOD & CANCER, vol. 68, no. 7, pp. 29044-29044. https://doi.org/10.1002/pbc.29044

TY - JOUR

T1 - Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review

AU - Sora', Federica

AU - Annunziata, Mario

AU - Laurenti, Luca

AU - Giammarco, Sabrina

AU - Chiusolo, Patrizia

AU - Innocenti, Idanna

AU - Autore, Francesco

AU - Metafuni, Elisabetta

AU - Galli, Eugenio

AU - Bacigalupo, Andrea

AU - Ferrara, Felicetto

AU - Sica, Simona

PY - 2021

Y1 - 2021

N2 - NOT AVAILABLE

AB - NOT AVAILABLE

KW - BLINATUMOMAB DOWN

UR - https://publicatt.unicatt.it/handle/10807/222578

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85104140578&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104140578&origin=inward

U2 - 10.1002/pbc.29044

DO - 10.1002/pbc.29044

M3 - Article

SN - 1545-5009

VL - 68

SP - 29044

EP - 29044

JO - PEDIATRIC BLOOD & CANCER

JF - PEDIATRIC BLOOD & CANCER

IS - 7

ER -

Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this